Cargando…

AstraZeneca COVID-19 vaccine: no increased rate of VTE

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035882/
http://dx.doi.org/10.1007/s40278-021-93813-z
_version_ 1783676794340114432
collection PubMed
description
format Online
Article
Text
id pubmed-8035882
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80358822021-04-12 AstraZeneca COVID-19 vaccine: no increased rate of VTE Reactions Weekly Clinical Study Springer International Publishing 2021-04-10 2021 /pmc/articles/PMC8035882/ http://dx.doi.org/10.1007/s40278-021-93813-z Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
AstraZeneca COVID-19 vaccine: no increased rate of VTE
title AstraZeneca COVID-19 vaccine: no increased rate of VTE
title_full AstraZeneca COVID-19 vaccine: no increased rate of VTE
title_fullStr AstraZeneca COVID-19 vaccine: no increased rate of VTE
title_full_unstemmed AstraZeneca COVID-19 vaccine: no increased rate of VTE
title_short AstraZeneca COVID-19 vaccine: no increased rate of VTE
title_sort astrazeneca covid-19 vaccine: no increased rate of vte
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035882/
http://dx.doi.org/10.1007/s40278-021-93813-z